Trial Profile
A Study to Evaluate the TNF-α Levels and it's Correlation with Clinical and Endoscopic Disease Activity in Patients with Crohn's Disease (CD) in Maintenance Treatment with Adalimumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Pharmacodynamics; Therapeutic Use
- 16 Dec 2015 New trial record